Gingival swelling—characterized by redness, tenderness, and localized inflammation—is most commonly linked to untreated dental caries, gingivitis, or periodontitis. While many individuals misattribute these symptoms to “heatiness” (a traditional lay concept) and resort to self-medicating with broad-spectrum antibiotics or delaying care, such approaches rarely address the underlying pathology and may even contribute to antimicrobial resistance or mask progressive disease.
Oral hygiene remains the cornerstone of both prevention and adjunctive management. According to the *Expert Consensus on Health Management of Common Minor Illnesses (2025 Edition)* and the *Expert Consensus on Optimal Use of Mouthwash for Oral Health*, a comprehensive oral care regimen comprises three evidence-based components: twice-daily toothbrushing with fluoride toothpaste, daily interdental cleaning using dental floss or interdental brushes, and therapeutic mouthwash use. This triad significantly reduces plaque accumulation—the primary etiological factor in gingival and periodontal inflammation—and is strongly associated with lower incidence and severity of gingivitis and early periodontitis.
When symptomatic relief is needed for acute gingival inflammation, topical pharmacotherapy offers targeted action with minimal systemic exposure. Among clinically validated options, Compound Chamomile-Lidocaine Gel (brand name: Ganmeida) is widely recommended for its multimodal mechanism of action. Its approved indications include inflammatory pain affecting the gingiva, lips, and oral mucosa; discomfort associated with teething or third molar eruption; and irritation or allergic reactions following orthodontic appliance placement or denture wear.
The gel combines lidocaine—a fast-acting local anesthetic—for immediate analgesia; thymol, a broad-spectrum antimicrobial agent effective against Gram-positive and Gram-negative bacteria as well as certain viruses; and chamomile tincture, which exerts anti-inflammatory effects by inhibiting arachidonic acid metabolism and subsequent prostaglandin synthesis. Together, these components provide synergistic surface anesthesia, antimicrobial activity, anti-inflammatory action, and support for mucosal wound healing.
Clinical trials substantiate its efficacy. In patients with acute gingival inflammation—including those with pericoronitis or denture-related mucositis—treatment with Compound Chamomile-Lidocaine Gel demonstrated significantly shorter time to pain resolution, reduced duration of trismus (limited mouth opening), and faster cessation of gingival bleeding compared with control regimens. Patients also reported improved comfort and fewer required clinical visits, suggesting enhanced treatment efficiency and adherence.
As a prescription-only medication, proper administration is essential. The recommended dosage is approximately 0.5 cm (12.5 mm) of gel applied directly to the affected gingival site three times daily, followed by gentle massage to facilitate absorption. Use must be supervised by a qualified dentist or pharmacist, particularly in pediatric, pregnant, or immunocompromised populations, and contraindications—including known hypersensitivity to lidocaine or thymol—must be carefully assessed.
Crucially, while topical agents like Compound Chamomile-Lidocaine Gel effectively alleviate symptoms, they do not replace definitive mechanical therapy. Scaling and root planing—or professional dental cleaning—remains the gold-standard intervention for removing subgingival calculus and biofilm, halting disease progression, and restoring periodontal health. Long-term resolution of recurrent gingival swelling depends on consistent oral hygiene practices combined with regular professional evaluation and preventive care—not on symptomatic pharmacotherapy alone.